VRCA Verrica Pharmaceuticals Inc.: institutional ownership and insider trading
44 funds reported holding $29.7M of Verrica Pharmaceuticals Inc. in their latest 13F filings; in Q2 2026 funds net sold $707K, with 8 new positions and 5 funds selling out; over the last 12 months insiders bought $18.2M and sold $0 on the open market; over its last four quarters it reported revenue of $30.3M and net income of −$31.2M.
VRCA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $5.86M, net income −$13.2M, EPS -0.62
- Quarter ended Mar 31, 2026: revenue $5.02M, net income −$9.68M, EPS -0.45
- Quarter ended Dec 31, 2025: revenue $5.09M, net income −$8.09M, EPS -0.64
- Quarter ended Sep 30, 2025: revenue $14.3M, net income −$274K, EPS -0.03
Famous investors holding VRCA
- Two Sigma (Two Sigma Investments): $250K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $133K, 0.0% of the portfolio
Largest institutional holders of VRCA
- Caligan Partners LP — $5.65M
- CANNELL CAPITAL LLC — $4.80M
- Affinity Asset Advisors, LLC — $4.33M
- Velan Capital Investment Management LP — $2.89M
- ARMISTICE CAPITAL, LLC — $2.61M
- BOOTHBAY FUND MANAGEMENT, LLC — $1.72M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.71M
- Mariner, LLC — $1.27M
- VANGUARD GROUP INC — $1.15M
- GEODE CAPITAL MANAGEMENT, LLC — $846K
Recent VRCA insider trades
- Aug 18, 2026: Kirby John J. bought 5,000 shares ($24.7K)
- Aug 18, 2026: Rosenberg Noah L. bought 6,230 shares ($30.6K)
- Aug 17, 2026: Rieger Jayson bought 25,000 shares ($126K)
- Aug 17, 2026: Zawitz David bought 6,000 shares ($29.9K)
5%+ owners
- Paul B Manning: 49.9% (Schedule 13D/A, filed Nov 28, 2025)
- Caligan Partners LP: 10.0% (Schedule 13D/A, filed Dec 30, 2025)
- Affinity Asset Advisors, LLC: 5.5% (Schedule 13G/A, filed Jan 29, 2026)
Who owns the most VRCA stock?
The largest institutional holders of Verrica Pharmaceuticals Inc. in the latest 13F filings are Caligan Partners LP ($5.65M), CANNELL CAPITAL LLC ($4.80M), Affinity Asset Advisors, LLC ($4.33M).
Are insiders buying or selling VRCA?
Over the last 12 months insiders bought $18.2M and sold $0 of Verrica Pharmaceuticals Inc. stock on the open market (SEC Form 4).
Which famous investors own VRCA?
Two Sigma, Renaissance Technologies.
What was VRCA's revenue last quarter?
Verrica Pharmaceuticals Inc. reported revenue of $5.86M for the quarter ended June 30, 2026, with net income of −$13.2M.